Merck Tepmetko

YES, I would like to receive email updates from Merck regarding products, programs, services, and events.

First name

Surname

Specialty

medical oncologist

oncology nurse

pathologist

pharmacist

other

Phone

Address line 1

Address line 2

Suburb Postcode

State

Reason for contact

PBS Information: Authority required (STREAMLINED).
Locally Advanced or Metastatic Non-Small Cell Lung Cancer with evidence of
MET exon 14 skipping alterations. Refer to PBS schedule for full authority information.

Before prescribing, please review the full Product Information available from www.medicines.org.au/files/sgptepme.pdf

▼

This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems

By agreeing to the terms and conditions below you are providing consent for Merck and its employees to facilitates communication with you via digital platforms. The digital platforms in this document shall mean any electronic tools for communication including but not limited to web-based messaging, email, SMS, social media, conferencing sharing facilities and webinars.

Regulations require we have your formal permission to keep you updated via digital platform in relation to product supply, continuity, other product information and surveys.

Merck will use such digital platforms to provide services and information to you, including educational material; safety related information; invitations to Merck educational events or information about Merck’s products, services, programs & business, clinical tools, questionnaires / surveys.

Merck will not provide your personal details to third parties except where that party is providing a service on behalf of Merck and has agreed to comply with the Merck Privacy Policy, which can be accessed at www.merck.com.au

Should you decide to unsubscribe in the future, Merck will continue to use digital communication to send important information, such as product recall or safety alerts, supply issues or similar essential communications.

Merck Healthcare Pty Ltd, ABN 72 006 900 830. Suite 1, Level , Building B, 11 Talavera Road, Macquarie Park NSW 2113 Australia.
Web: www.merck.com.au. Phone: 1800 257 348. AU-TEP-00040. MERC0050/EMBC. Date of preparation: October 2022